Unusual Salmonella enterica serotype Typhimurium isolate producing CMY-7, SHV-9 and OXA-30 β-lactamases

Nancy D. Hanson, Ellen S. Moland, Ashfaque Hossain, Stephen A. Neville, Iain B. Gosbell, Kenneth S. Thomson

Research output: Contribution to journalArticle

53 Scopus citations

Abstract

β-Lactam resistance in Salmonella isolates is increasing. This paper describes the combination of three different β-lactamases, OXA-30, SHV-9 and CMY-7, expressed by an isolate of Salmonella enterica serotype Typhimurium. This is the first report of an isolate of Salmonella having both an extended-spectrum β-lactamase and an AmpC β-lactamase.

Original languageEnglish (US)
Pages (from-to)1011-1014
Number of pages4
JournalJournal of Antimicrobial Chemotherapy
Volume49
Issue number6
StatePublished - Jul 8 2002

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Microbiology (medical)
  • Infectious Diseases
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Unusual Salmonella enterica serotype Typhimurium isolate producing CMY-7, SHV-9 and OXA-30 β-lactamases'. Together they form a unique fingerprint.

  • Cite this

    Hanson, N. D., Moland, E. S., Hossain, A., Neville, S. A., Gosbell, I. B., & Thomson, K. S. (2002). Unusual Salmonella enterica serotype Typhimurium isolate producing CMY-7, SHV-9 and OXA-30 β-lactamases. Journal of Antimicrobial Chemotherapy, 49(6), 1011-1014.